CLL is also characterized by distinct immunophenotypes, presenting deficiencies such as autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), and immune neutropenia, in addition to the presence of CD5+, CD19+, CD20DIM, CD23+ cells [73]. The gene discussed is CD19; the disease is autoimmune hemolytic anemia.